Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials

References

• Bogousslavsky J, Van Melle G, Regli F. The Lausanne stroke registry: analysis of 1,000 consecutive patients with first stroke. Stroke. 1988;19:1083–1092.
   PubMed Web of Science ®Google Scholar
• Libman RB, Sacco RL, Shi T, et al. Neurologic improvement in pure motor hemiparesis: implications for clinical trials. Neurology. 1992;42:1713–1716.
   PubMed Web of Science ®Google Scholar
• Carmelo C. Bottom-up or top-down approach? Understanding the way to reach the milestone of recovery in stroke. Int J Neurorehabil. 2015;02:107.
   Google Scholar
• Warner JJ, Harrington RA, Sacco RL, et al. Guidelines for the early management of patients with acute Ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019;50:3331–3332.
   PubMed Web of Science ®Google Scholar
• Walker RF. A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology. 2013;67:304–317.
   PubMed Web of Science ®Google Scholar
• Bilge C, Koer E, Koer A, et al. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med. 2008;44:13–18.
   PubMed Web of Science ®Google Scholar
• Tallelli P, Werring DJ. Pharmacological augmentation of motor recovery after stroke: antidepressants for non-depressed patients? J Neurol. 2009;256:1159–1160.
   PubMed Web of Science ®Google Scholar
• Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair. 2008;22:311–314.
   PubMed Web of Science ®Google Scholar
• Acler M, Robol E, Fiaschi A, et al. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol. 2009;256:1152–1158.
   PubMed Web of Science ®Google Scholar
• Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996;27:1211–1214.
   PubMed Web of Science ®Google Scholar
• Kong Y, Dong W, Liu C. Fluoxetine for poststroke depression: a randomized placebo controlled clinical trial. Neural Regen Res. 2007;2:162–165.
   Google Scholar
• Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123–130.
   PubMed Web of Science ®Google Scholar
• FOCUS Trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet. 2018;393:265–274.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available from: http://www.cochrane-handbook.org
   Google Scholar
• Higgins JPT. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Asadollahi M, Ramezani M, Khanmoradi Z, et al. The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial. Clin Rehabil. 2018;32:1069–1075.
   PubMed Web of Science ®Google Scholar
• Zhao-Sheng D, Fang Z, Ma-Ming L, et al. Influence and clinical effect of fluoxetine on the level of serum brain-derived neurotrophic factor in patients with ischemic stroke. JClin Med Pract. 2012;16:17–19.
   Google Scholar
• Dike FO, Ekeh BC, Ogun AS, et al. Pharmacological enhancement of motor function recovery in patients with ischaemic stroke: a trial of fluoxetine. J Neurol Stroke. 2019;9:47–51.
   Google Scholar
• Xi-Ping G. Effect of fluoxetine on improving motor function of severely paralyzed limbs after acute cerebral infarction. Chin J Pract Nerv Dis. 2017;20:99–101.
   Google Scholar
• Xian-Zhi H. Analysis of the effect of rehabilitation therapy combined with fluoxetine in the treatment of cerebral infarction. Chin J Pract Nerv Dis. 2015;18:53–54.
   Google Scholar
• Jie H, Jun L, Honglian Z, et al. Effect of fluoxetine for motor recovery after acute cerebral infarction. Chin J Med Guide. 2012;14:639–640.
   Google Scholar
• Yingying H, Zhenhua L, Qingcheng Y, et al. Effect of fluoxetine on motor function of patients with acute ischemic stroke. Chin J Pract Nerv Dis. 2013;16:48–49.
   Google Scholar
• Binlong J, Xueting W. Effect of prophylactic antidepressant treatment with citalopram on motor function recovery in patients with acute cortical infarction. Int J Cerebrovasc Dis. 2015;23:593–596.
   Google Scholar
• Yan L, Xinyue Q, Xiurong L. Effects of fluoxetine on the recovery of motor function and magnetic stimulation MEP after stroke. Chongqing Med. 2000;29:58–60.
   Google Scholar
• Haitao L, Laihui F, Hongying B. The clinical research of fluoxetine on motor functional recovery after the acute cerebral infarction in anterior circulation. Chin J Pract Nerv Dis. 2014;17:28–30.
   Google Scholar
• Ma N. The efficacy and safety of early adjuvant fluoxetine on the prognosis of motor function in patients with acute cerebral infarction. Chin Med Guide. 2015;13:137.
   Google Scholar
• Marquez-Romero JM, Reyes-Martínez M, Huerta-Franco MR, et al. Fluoxetine for motor recovery after acute intracerebral hemorrhage, the FMRICH trial. Clin Neurol Neurosurg. 2019;190:105656.
   PubMed Web of Science ®Google Scholar
• Xiao-Ling P, Hong-Fang C, Xing C, et al. Effects of paroxetine on motor and cognitive function recovery in patients with non-depressed ischemic stroke: an open randomized controlled study. Brain Impairment. 2018;19:1–7.
   Web of Science ®Google Scholar
• Yongjun P, Nengwei Y. Effect of fluoxetine on motor and cognitive functions deficits in acute cerebral infarction patients. J Wuhan Univ. 2015;36:461–463.
   Google Scholar
• Ahmad Shah I. Effect of fluoxetine on motor recovery after acute haemorrhagic stroke: arandomized trial. J Neurol Neurophysiol. 2016;07:1–5.
   Google Scholar
• Heng W, Zhenli G, Rui Z, et al. Effect of fluoxetine-assisted rehabilitation therapy on motor function of patients with acute cerebral infarction. Chin J Phys Med Rehabil. 2013;35:872–874.
   Google Scholar
• Jing X, Yuanyuan H, Side J, et al. Influence of early application of citalopram on motor function recovery of patients with acute cortical cerebral infarction. J Clin Med Pract. 2017;21:5–7.
   Google Scholar
• Jianjun Y, Jie H, Jiangrong X, et al. Clinical trial of fluoxetine on motor recovery after spontaneous intracerebral hemorrhage. Chin J Clin Pharmacol. 2016;32:1643–1645.
   Google Scholar
• Yueping Z, Jun W, Luping S, et al. The effects of fluoxetine on neurological function in patients with hemiplegia after stroke. Med J West China. 2014;26:1593–1595.
   Google Scholar
• Yihong Z, Suijun T, Xingkai A, et al. Effect of escitalopram on motor recovery after acute ischemic stroke. Chin Hosp Pharm J. 2014;034:752–755.
   Google Scholar
• Ning Z. Sertraline motor function in patients with cerebral apoplexy hemiplegia rehabilitation. Xinxiang Medical University Press, CHN; 2016.
   Google Scholar
• Legg LA, Tilney R, Hsieh CF, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2019;26;2019:CD009286.
   Google Scholar
• EFFECTS Trial Collaboration. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19:661–669.
   PubMed Web of Science ®Google Scholar
• AFFINITY Trial Collaboration. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19:651–660.
   PubMed Web of Science ®Google Scholar
• Yeo S-H, Lim Z-JI, Mao J, et al. Effects of central nervous system drugs on recovery after stroke: a systematic review and meta-analysis of randomized controlled trials. Clin Drug Investig. 2017;37(10):901–928.
   PubMed Web of Science ®Google Scholar
• Mead GE, Hsieh CF, Lee R, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012;11:CD009286.
   PubMedGoogle Scholar
• Zhou S, Liu S, Liu X, et al. Selective serotonin reuptake inhibitors for functional Independence and depression prevention in early stage of post-stroke: a meta-analysis. Medicine (Baltimore). 2020;99:e19062.
   PubMed Web of Science ®Google Scholar
• Hackam DG, Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology. 2012;79:1862–1865.
   PubMed Web of Science ®Google Scholar
• Mortensen JK, Larsson H, Johnsen SP, et al. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke. 2013;44:420–426.
   PubMed Web of Science ®Google Scholar
• Pinto CB, Saleh Velez FG, Fernanda L, et al. SSRI and motor recovery in stroke: reestablishment of inhibitory neural network tonus. Front Neurosci. 2017;11:637.
   PubMed Web of Science ®Google Scholar
• Dimyan MA, Cohen LG. Neuroplasticity in the context of motor rehabilitation after stroke. Nat Rev Neurol. 2011;7:76–85.
   PubMed Web of Science ®Google Scholar
• Pekna M, Pekny M, Nilsson M. Modulation of neural plasticity as a basis for stroke rehabilitation. Stroke. 2012;43:2819–2828.
   PubMed Web of Science ®Google Scholar
• Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol. 2007;18:391–418.
   PubMed Web of Science ®Google Scholar